202 related articles for article (PubMed ID: 25197373)
1. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
2. DEK over expression as an independent biomarker for poor prognosis in colorectal cancer.
Lin L; Piao J; Gao W; Piao Y; Jin G; Ma Y; Li J; Lin Z
BMC Cancer; 2013 Jul; 13():366. PubMed ID: 23902796
[TBL] [Abstract][Full Text] [Related]
3. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
[TBL] [Abstract][Full Text] [Related]
4. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
5. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
[TBL] [Abstract][Full Text] [Related]
6. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
7. CD3, CD8, IFN-γ, tumor and stroma inflammatory cells as prognostic indicators for surgically resected SCLC: evidences from a 10-year retrospective study and immunohistochemical analysis.
Fu M; Feng C; Wang J; Guo C; Wang Y; Gao R; Wang J; Zhu Q; Zhang X; Qi J; Zhang Y; Bian Y; Wang Z; Fang Y; Cao L; Hong B; Wang H
Clin Exp Med; 2024 May; 24(1):99. PubMed ID: 38748269
[TBL] [Abstract][Full Text] [Related]
8. The downregulation of Bcl-xL/Bcl-2-associated death promoter indicates worse outcomes in patients with small cell lung carcinoma.
Yu Y; Zhong Z; Guan Y
Int J Clin Exp Pathol; 2015; 8(10):13075-82. PubMed ID: 26722503
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of SOX2 and FGFR1 in correlation with poor prognosis in patients with small cell lung cancer.
Yang F; Gao Y; Geng J; Qu D; Han Q; Qi J; Chen G
Int J Clin Exp Pathol; 2013; 6(12):2846-54. PubMed ID: 24294370
[TBL] [Abstract][Full Text] [Related]
12. Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.
Gao Y; Geng J; Hong X; Qi J; Teng Y; Yang Y; Qu D; Chen G
Int J Clin Exp Pathol; 2014; 7(2):760-7. PubMed ID: 24551300
[TBL] [Abstract][Full Text] [Related]
13. High expression of DEK is associated with poor prognosis in hepatocellular carcinoma.
Lee SY; Jung W; Lee J; Kim A; Kim HK; Kim BH
Histol Histopathol; 2019 Nov; 34(11):1279-1288. PubMed ID: 31066459
[TBL] [Abstract][Full Text] [Related]
14. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
[TBL] [Abstract][Full Text] [Related]
15. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
16. Expression of Notch1 and Numb in small cell lung cancer.
Kikuchi H; Sakakibara-Konishi J; Furuta M; Yokouchi H; Nishihara H; Yamazaki S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Harada T; Higuchi M; Honjo O; Minami Y; Watanabe N; Oizumi S; Suzuki H; Ishida T; Dosaka-Akita H; Isobe H; Munakata M; Nishimura M
Oncotarget; 2017 Feb; 8(6):10348-10358. PubMed ID: 28060745
[TBL] [Abstract][Full Text] [Related]
17. DEK: A novel early screening and prognostic marker for breast cancer.
Ying G; Wu Y
Mol Med Rep; 2015 Nov; 12(5):7491-5. PubMed ID: 26459608
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
19. DEK depletion negatively regulates Rho/ROCK/MLC pathway in non-small cell lung cancer.
Wang J; Sun L; Yang M; Luo W; Gao Y; Liu Z; Qiu X; Wang E
J Histochem Cytochem; 2013 Jul; 61(7):510-21. PubMed ID: 23571382
[TBL] [Abstract][Full Text] [Related]
20. Bcl-2 as a prognostic factor for survival in small-cell lung cancer.
Ilievska Poposka B; Smickova S; Jovanovska Crvenkovska S; Zafirovska Ivanovska B; Stefanovski T; Petrusevska G
Prilozi; 2008 Dec; 29(2):281-93. PubMed ID: 19259053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]